Featured Articles

  1. Testing Federal Healthcare Laws: Risks In Genetic-Testing Programs 3/13/2025

    Sponsored genetic testing programs can run afoul of federal laws, including the FCA and AKS, if not designed correctly. Experts at Morrison Foerster share best practices for compliance.

  2. Pharma's Guide To Making Health Communications Land Well 3/11/2025

    New treatment paradigms are making biopharma industry stakeholder communications more ambitious and complex. But they must also be credible and consumable, writes Michelle Bridenbaker.

  3. AI In A Time Of Uncertainty: Key Strategies To Enable Flexibility 3/4/2025

    Given the near-constant technological advancements in AI, potential AI policy updates, and regulatory changes, flexible AI systems are necessary for life science organizations to keep pace with change.

  4. A CEO With A General Counsel's Perspective 2/28/2025

    LB Pharmaceuticals CEO Heather Turner explains why 18 years as a general counsel provided her with an advantageous perspective on the CEO role.

  5. Interchangeability In Leadership: A Career Built On Versatility 2/27/2025

    Adaptability serves as the foundation for lasting career success, shaping leaders who can thrive in an ever-changing business landscape, explains Mary Beth Sandin.

  6. An Updated View of The Federal Segment: DHA Formulary Management 2/25/2025

    Part two of a three-part series aimed at helping drug and device manufacturers better navigate and understand the Veterans Affairs and Department of Defense health systems.

  7. FCPA Enforcement Paused At DOJ, But Biopharma Shouldn't Pause Compliance 2/21/2025

    Criminal enforcement of the Foreign Corrupt Practices Act was paused on February 10 by a Trump administration executive order. That doesn't mean biopharmaceutical companies can backslide on compliance in global markets.

  8. A Guide To Successful Product Launches For Small And Midsized Biotechs 2/19/2025

    Abhijit Naravane, a partner at PA Consulting, outlines strategies to help biopharma operations leaders successfully navigate the complexities of a product launch.

     

  9. Where Are They Now? Tarsus Pharmaceuticals 2/13/2025

    Tarsus Pharmaceuticals is making a splash with Xdemvy, an eye drop that kills the demodex mites that cause inflammation and irritation in the eyelid. A new consumer DTC campaign, potential global approvals, and a new indication in the clinic could turn Xdemvy into a blockbuster drug.

  10. Tax Planning For Life Sciences Amid Shifting Policies 2/11/2025

    Tax policy shifts can directly affect corporate structure decisions, overall business strategy, and the ability to allocate resources effectively. In 2025, staying ahead of these changes will be vital, writes life sciences tax expert Richard Weiner.